XOMA Corp (XOMA)
25.03
-0.48
(-1.88%)
USD |
NASDAQ |
May 20, 16:00
25.85
+0.82
(+3.28%)
After-Hours: 20:00
XOMA Price to Book Value: 3.54 for May 20, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 20, 2024 | 3.54 |
| May 17, 2024 | 3.608 |
| May 16, 2024 | 3.629 |
| May 15, 2024 | 3.495 |
| May 14, 2024 | 3.619 |
| May 13, 2024 | 3.645 |
| May 10, 2024 | 3.598 |
| May 09, 2024 | 3.350 |
| May 08, 2024 | 3.423 |
| May 07, 2024 | 3.468 |
| May 06, 2024 | 3.539 |
| May 03, 2024 | 3.504 |
| May 02, 2024 | 3.597 |
| May 01, 2024 | 3.651 |
| April 30, 2024 | 3.583 |
| April 29, 2024 | 3.747 |
| April 26, 2024 | 3.593 |
| April 25, 2024 | 3.586 |
| April 24, 2024 | 3.626 |
| April 23, 2024 | 3.689 |
| April 22, 2024 | 3.651 |
| April 19, 2024 | 3.603 |
| April 18, 2024 | 3.477 |
| April 17, 2024 | 3.429 |
| April 16, 2024 | 3.447 |
| Date | Value |
|---|---|
| April 15, 2024 | 3.442 |
| April 12, 2024 | 3.655 |
| April 11, 2024 | 3.705 |
| April 10, 2024 | 3.645 |
| April 09, 2024 | 3.621 |
| April 08, 2024 | 3.569 |
| April 05, 2024 | 3.583 |
| April 04, 2024 | 3.648 |
| April 03, 2024 | 3.652 |
| April 02, 2024 | 3.726 |
| April 01, 2024 | 3.570 |
| March 31, 2024 | |
| March 28, 2024 | 3.156 |
| March 27, 2024 | 3.062 |
| March 26, 2024 | 3.038 |
| March 25, 2024 | 3.149 |
| March 22, 2024 | 3.254 |
| March 21, 2024 | 3.219 |
| March 20, 2024 | 3.230 |
| March 19, 2024 | 3.307 |
| March 18, 2024 | 3.304 |
| March 15, 2024 | 3.451 |
| March 14, 2024 | 3.379 |
| March 13, 2024 | 3.358 |
| March 12, 2024 | 3.363 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.350
Minimum
Sep 13 2022
13.21
Maximum
Dec 21 2020
3.843
Average
2.961
Median
Aug 04 2021
Price to Book Value Benchmarks
| Societal CDMO Inc (DELISTED) | 1.982 |
| AbbVie Inc | 36.29 |
| AnaptysBio Inc | 14.30 |
| Kinnate Biopharma Inc (DELISTED) | 0.7855 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 49.54 |
| PEG Ratio | -0.1302 |
| Price | 25.03 |
| Earnings Yield | -15.66% |
| Market Cap | 291.31M |